Join the Wegovy group to help and get support from people like you.
Wegovy News (Page 9)
Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity
TUESDAY, Sept. 3, 2024 – Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according...
Taking Wegovy, Zepbound? One Expert Has Dietary Advice
TUESDAY, Sept. 3, 2024 – Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health. But they still need to eat a high-quality diet if they want to m...
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds
TUESDAY, Sept. 3, 2024 – The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules...
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
FRIDAY, Aug.30, 2024 – New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of...
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
WEDNESDAY, Aug. 28, 2024 – Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or...
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
MONDAY, Aug. 26, 2024 – Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine. After the Semaglutide Effects on...
3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules
TUESDAY, Aug. 27, 2024 – New Medicare rules could make 3.6 million Americans – or even more – eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds. Under the new...
Wegovy Helps Patients With Heart Failure Avoid Heart Attack, Stroke
FRIDAY, Aug. 23, 2024 – Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart attacks and strokes, and now more data from the...
Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality Analysis
WEDNESDAY, Aug. 21, 2024 – Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open. Georgios...
GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes
MONDAY, Aug. 12, 2024 – Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor...
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
WEDNESDAY, Aug. 7, 2024 (HealthDay news) – Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds. Medicaid...
2021 to 2023 Saw Considerable Increase in Semaglutide Fills
MONDAY, Aug. 5, 2024 – From 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum....
Semaglutide Products Being Sold Online Without Prescriptions
FRIDAY, Aug. 2, 2024 – Semaglutide products are being sold online, with products likely unregistered or unlicensed, according to a research letter published online Aug. 2 in JAMA Network Open. Amir...
Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder
MONDAY, July 29, 2024 – For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures...
FDA Warns of Accidental Overdoses from Compounded Versions of Ozempic
TUESDAY, July 30, 2024 – People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns. These ODs typically are due to miscommunications...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction